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Abstract
Background: The epidemiology of Molluscum contagiosum (MC) in the United States is largely unknown, despite the fact
that the virus is directly communicable and large outbreaks occur. This study provides population-based estimates to
describe the epidemiology of MC in the United States among American Indian and Alaska Native (AI/AN) persons. This
population was selected because of the comprehensiveness and quality of available data describing utilization of out-
patient services.
Principal Findings: Outpatient visits listing MC as a diagnosis in the Indian Health Service National Patient Information
Reporting System during 2001–2005 were analyzed to assess patient characteristics, visit frequency and concurrent skin
conditions. Outpatient visit rates and incidence rates were calculated based on known population denominators
(retrospective cohort). Overall outpatient visit rates were also calculated for the general US population using national data.
The average annual rate of MC-associated outpatient visits was 20.15/10,000 AI/AN persons for 2001–2005 (13,711 total
visits), which was similar to the rate for the general US population (22.0/10,000 [95% CI: 16.9–27.1]). The incidence of MC-
associated visits was 15.34/10,000. AI/AN children 1–4 years old had the highest incidence (77.12), more than twice that for
children 5–14 years old (30.79); the incidence for infants (,1 year) was higher than that for adults. AI/AN persons living in
the West region had the highest incidence, followed by those in the East and Alaska regions (26.96, 22.88 and 21.38,
respectively). There were age-specific associations between MC and concurrent skin conditions (e.g., atopic dermatitis,
eczema).
Conclusions: This study highlights the need for periodic population-based measurements to assess trends in incidence and
healthcare utilization for MC in the United States. High rates of MC were found among AI/AN persons, especially among
children ,15 years old. The AI/AN population would benefit from greater availability of effective strategies for prevention
and treatment of MCV infection.
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Introduction
Molluscum contagiosum (MC) is a superficial infection of the
dermis caused by a virus in the family Poxviridae. In otherwise
healthy individuals, infection with Molluscum contagiosum virus
(MCV) results in a benign self-limiting condition marked by the
formation of distinctive, persistent dermal lesions that evolve
slowly over the course of several weeks to several months. The
total time-course of infection may be prolonged due to inadvertent
autoinoculation of the virus to other parts of the body. Activities or
circumstances that involve skin-to-skin contact (e.g., play, sports
such as wrestling, sexual activity, etc.) have been associated with
increased risk for infection [1].
Because of the characteristic appearance of MC lesions,
diagnosis is generally made without laboratory testing. Often
specific treatments or therapies are not pursued for MC infection
in immune competent individuals, as lesions will resolve with time,
however, mechanical removal (via curettage, cryotherapy, or laser
treatment) and various topical therapies (including tretinoin,
cantharidin, Imiquimod, cidofovir) are sometimes utilized to
minimize the duration that lesions are present, particularly on
the face or on areas of the body that are subject to heightened
irritation. Molluscum contagiosum in persons who have immune
compromise—whether due to HIV infection, immunosuppressive
drug therapies, or other reasons—can be complicated.
Persons with atopic dermatitis (i.e., eczema) are generally
considered to be at greater risk for contracting MC due to immune
deficits, compromised skin integrity, or both [2–4]. However,
investigations into the association between atopic dermatitis and
molluscum infection have been observational in nature and have
principally addressed the conditions only in children. In general,
epidemiologic studies of MC are few and most have focused on
rates of infection or risk factors for infection in specific population
subgroups. These subgroups have been defined variously by
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[9,10] or the type of medical service facility at which they had
sought care (e.g., tertiary care facilities, dermatology specialists,
etc.) [7,11]. Provision of population-based incidence rates for MC,
which would allow for comparison across studies, is rare.
With this study we seek to provide an extensive description of
the epidemiology of MC among American Indian and Alaska
Native (AI/AN) persons, a subset of the general US population.
The AI/AN population is not anticipated to directly reflect the
broader US population with respect to health issues – AI/AN
communities are often subject to considerable health disparities—
but approximately 57% of the AI/AN population across the
United States is served by the Indian Health Service (IHS);
therefore utilization of healthcare services through the IHS can
provide a broadly encompassing, population-based, view of
specific health-related issues including infection with MCV. The
IHS National Patient Information Reporting System (NPIRS),
which records 100% of clinic and ambulatory care records for all
IHS-contracted or operated facilities, captures population-based
outpatient visit data through time from across the United States
for all AI/AN age groups. This study, which spans five years,
represents the largest, most comprehensive molluscum survey
performed to date. The MC-associated outpatient visit rate for
AI/AN persons is compared with that of the general US
population (derived from data available through the National
Ambulatory Medical Care Survey [NAMCS] and the National
Hospital Ambulatory Medical Care Survey [NHAMCS]). Patient-
based MC-associated outpatient visit rates or incidence among
AI/AN persons are examined.
Methods
The IHS direct and contract outpatient visit data for AI/AN
persons for calendar years 2001–2005, obtained from the IHS
National Patient Information Reporting System (NIPRS), were
analyzed [12]. The direct and contract health service outpatient
visit data consist of all direct and contract health care outpatient
visit records from IHS-and tribally-operated facilities and facilities
which are contracted with the IHS or with specific tribes to
provide healthcare services to eligible AI/AN persons [12,13]. All
AI/AN persons in this study received IHS-funded health care and
may not be representative of all AI/AN persons in the United
States.
Molluscum contagiosum-associated outpatient visit records,
where MC was listed as one of up to nine diagnoses, were
selected for analysis. Visits with MC listed as one of up to three
diagnoses were selected from the US ambulatory care data. The
International Classification of Diseases, 9
th Revision, Clinical Modification
(ICD-9-CM) code 078.0 was used to define MC [14]. The IHS
provided outpatient visits by patient (no unique identifiers were
provided to investigators), which enabled the examination of
multiple outpatient visits for patients and estimation of the
incidence of MC. The patient’s first annual MC visit during each
year of the study period was used for patient-based analysis to
estimate the incidence, reported as number of AI/AN persons
with at least one MC-associated outpatient visit per 10,000 AI/AN
persons. Because this study only encompasses individuals who
have sought healthcare while infected with MCV, it is likely to be a
minimum estimate of the true incidence of MC in the AI/AN
population. The primary unit of the analysis in this study was the
patient, unless otherwise stated.
Both molluscum contagiosum-associated outpatient visits and
patient-based outpatient visits for 2001–2005 among AI/AN
persons were examined by age group (,1 year [infants],1–4, 5–14,
15–19, 20–44, 45–64 and $65 years), IHS region (West Northern
Plains [Aberdeen and Billings areas], East Northern Plains
[Bemidji area], Southern Plains [Oklahoma area], Southwest
[Albuquerque, Navajo, Phoenix and Tucson areas], East [Nash-
ville area], Alaska, and West [California and Portland areas]), sex
and etiology. Month of visit and diagnoses listed with a MC
diagnosis on the record were examined. Annual outpatient visit
rates and incidence rates were calculated and expressed as the
number of outpatient visits and patients per 10,000 AI/AN
persons, respectively. The IHS user population estimates of AI/
AN persons within the IHS healthcare system for fiscal years
2001–2005 were used to calculate the rates [13,15]. The user
population is all AI/AN persons who were eligible to receive IHS-
funded healthcare service during the 5-year study period. Rate
comparisons among AI/AN persons were evaluated by charac-
teristic using risk ratios (RRs) with 95% confidence intervals (CIs)
[16]. Comparisons of the interval in days between outpatient
clinical visits by age group were made using the Wilcoxon rank-
sum test.
Table 1. Characteristics of molluscum contagiosum-
associated outpatient visits and average annual outpatient
visit rate among American Indians and Alaska Natives, 2001–
2005*.
Characteristic No.
Average annual
visit rate/10,000 persons
Total 13711 20.15
Gender
{
Male 6436 19.80
Female 7275 20.47
Age Group (years)
,1 223 21.85
1–4
{ 5731 102.98
5–14 5746 40.41
15–19 570 8.04
20–44 1223 4.91
45–64 174 1.58
$65 44 1.05
Region
1
Alaska 1736 28.64
East 599 31.08
Northern Plains, East 1115 25.64
Northern Plains, West 2194 23.83
Southern Plains 1769 12.15
Southwest 3433 14.39
West 2865 35.42
*Values reflect the outpatient visits associated with molluscum contagiosum
(MC) over the five-year study period (average annual population 1,360,847)
among American Indians and Alaska Natives using the IHS healthcare system.
A total of 2545 patients had multiple MC-associated visits during this period.
{The average annual rates of MC-associated outpaient visits for males and
females in the general US population for 2001–2005 are 20.3/10,000 (95% C.I
13.0–27.6) and 17.8/10,000 (95% CI 10.9–24.7) persons, respectively.
{The average annual rate of MC-associated outpatient visits for 1–4 year olds in
the general US population is 82.6/10,000 (95% C.I. 44.8–120.4). The low
number of visits for other corresponding age groups precludes reliable
population-based occurrence estimates.
1see Figure 2 [map of US with different geographic regions highlighted].
doi:10.1371/journal.pone.0005255.t001
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outpatient visit rates were examined for the general US
population. NAMCS and NHAMCS for 2001–2005 were used
to examine outpatient visits [17,18]. The NAMCS and NHAMCS
provide data with respect to outpatient visits and provide an
assessment of outpatient visits for the general US population. The
basic sampling unit for the NAMCS is the physician-encounter.
Only visits to the offices of non-federally employed physicians
classified by the American Medical Association or the American
Osteopathic Association as ‘‘office-based, patient care’’ are
included. The NHAMCS comprises a national probability sample
of visits to the emergency and outpatient department of non-
institutional general and short-stay hospitals. The US national
NAMCS and NHAMCS data in this study do not include IHS/
tribal facility outpatient visits or identify multiple hospitalizations
by patient. For the general US population, the outpatient visit rate
was expressed per 10,000 persons using the US Census estimates
[19]. Standard errors of NAMCS and NHAMCS estimates were
calculated by using SUDAAN software to account for the
sampling designs [20], and used to calculate 95% CIs for the
rates [16]. If the relative SE of estimates exceeded 0.30 or if the
number of unweighted visits in a strata was ,30, the estimates
were considered unreliable and are not reported [17,18].
Results
Molluscum contagiosum-associated outpatient visits (all
visits)
For 2001–2005, the average annual rate of MC-associated
outpatient visits for the general US population was estimated to be
22.0/10,000 (95% CI 16.9–27.1) based on an estimated 2,773,792
visits (SE=396,947). This rate is similar to that for the AI/AN
population (20.15/10,000; Table 1), derived from the reported
13,711 MC-associated outpatient visits among AI/AN persons
within the IHS healthcare system.
The number and rate of MC-associated outpatient visits in the
AI/AN population were similar for males and females, with males
experiencing 6436 MC-associated outpatient visits during the 5-
year period and females 7275 visits, corresponding to annual visit
rates per 10,000 of 19.80 and 20.47, respectively (Table 1). These
rates were similar to those for males and females in the general US
population (17.8 [95% CI=10.9–24.7] and 20.3 [95% CI=13.0–
27.6], respectively).
Non-infant, pre school-aged AI/AN children (1–4 years of age)
exhibited the highest rate of MC-associated outpatient visits
(102.98/10,000) compared to the other age groups, though there
were nominally more total outpatient visits among school-aged (5–
14 year old) children (5731 and 5746 visits, respectively; Figure 1).
The outpatient visit rates of MC-associated outpatient visits
were highest in the West and East regions (35.42 [RR=2.46. 95%
CI 2.34–2.59] and 31.08 [RR=2.16. 95% CI 1.98–2.36] vs. the
Southwest region, respectively), and lowest in the Southern Plains
(12.15 [RR=0.84, 95% CI 0.80–0.89], vs. the Southwest region)
(Table 1, Figure 2). The rate of MC-associated outpatient visits
was also higher in the Alaska region (28.63) than in the Southwest
region (RR=1.99, 95% CI 1.88–2.1). Visit rates for the West, East
and Alaska regions are all higher than the estimated rate for the
general US population.
No annual temporal trends of MC outpatient visits were evident
over the five-year period of observation (Figure 3). No statistically
significant differences, in terms of region, sex, or age, were
observed for outpatient visits between the first two years of the
observation period (2001, 2002) and the last (2004, 2005). The
average annual MC-associated outpatient visit rate was also not
significantly different for 2004–2005 relative to that for 2001–2002
(20.28 and 19.70, respectively; RR=1.03, 95% CI 0.99–1.07).
Figure 1. Molluscum contagiosum (MC)-associated outpatient visits among American Indian/Alaska Native persons by age (in
years), 2001–2005. The average number of MC-associated IHS/tribal outpatient visits per year over the 5-year period is depicted along the left axis.
Cumulative percent is shown along the opposing axis.
doi:10.1371/journal.pone.0005255.g001
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Though typically benign, infection with MCV can result in a
protracted condition spanning multiple clinic visits. Therefore, in
addition to assessing characteristics related to the total number of
MC-associated outpatient visits among AI/AN persons (above), we
also assessed characteristics of MC-associated outpatient visits by
patient, considering only each patient’s first annual MC-associated
visit during each year of the study period, termed here mean
annual incidence or ‘incidence’; the incidence was also analyzed
by age, sex and region (Table 2).
During the 5-year period, 10,441 AI/AN persons incurred at
least one MC-associated outpatient visit, corresponding to a mean
annual incidence of 15.3 cases/10,000 (Table 2). The incidence of
MC was similar for males and females regardless of region, except
in the Southern Plains area where incidence rates were low and
males overall exhibited a significantly higher annual mean
incidence than that for females (10.6 and 8.9/10,000, respectively;
RR=1.20, 95% CI=1.08–1.33). Stratified by age group and
region, the highest mean annual incidence of MC was observed for
1–4 year olds in the West and East regions (150.1/10,000 and
123.6/10,000, respectively; RR=1.21, 95% CI=1.04–1.42),
significantly higher than was observed for the same age group in
Alaska, which experienced the next highest rate (97.56/10,000;
RR=1.27, 95% CI 1.07–1.50, Alaska vs East). The highest
incidence among infants was recorded in the East and West
regions (55.8/10,000 and 38.6/10,000, respectively; RR=1.45,
95% CI=0.78–52.69), although the highest rate is based on a
relatively small number of observations (14).
Both the number of incident cases and the mean annual
incidence of MC demonstrated a trend of modest increase over the
5-year period of observation. The incidence was 19.70 in 2001–
2002 and 20.27/10,000 in 2004–2005 (RR=1.07, 95% CI: 1.03–
1.11; Table 3).
Characteristics of patients with multiple molluscum
contagiosum-associated outpatient visits
During the course of the study period, approximately 26% of
AI/AN persons (2545) experienced more than one outpatient visit
for which MC was indicated as a diagnosis. Overall, the mean
number of MC-associated visits per patient in this population was
1.4 (median 1.0), and was similar regardless of whether MC was
the principal or ancillary diagnosis for the visit (Figure 4). Two
percent of patients in this study had as many as 4 MC-associated
outpatient visits during the 5-year study period, and one patient
experienced at least 11 visits. Individuals 45–64 years of age were
the least likely to have multiple MC-associated outpatient visits;
only 16.5% had more than one visit, whereas 28.2% of 1–4 year
olds had a diagnosis of MC rendered over the course of multiple
outpatient visits (Chi-square p,0.01). The highest mean number
of visits per person occurred among the oldest patient in the West
and Southwest regions, 4.0 and 3.0, respectively.
Across the population of patients the median number of days
between MC-associated visits was lengthy at 42 days (quar-
tiles=15, 102). The median interval between visits was, however,
significantly shorter for those aged 45–64 years, although not
different from that for infants (median 24 vs 28.5 days,
respectively, p=0.83). The median interval between visits was
longest among patients 1–4 years of age (median 49 vs 42 days for
those aged 5–14 years, p=0.05).
Molluscum contagiosum with other diagnosed
dermatologic conditions
Ancillary diagnoses for all MC-associated outpatient clinic visits
among AI/AN persons were assessed to identify significant
concurrent skin conditions. Diagnoses associated with atopic
dermatitis and conditions indicative of immune deficits with
dermatologic manifestations (i.e., eczema) were categorized
Figure 2. Average annual rate of molluscum contagiosum-
associated outpatient visits per 10,000 American Indian/Alaska
Native persons by Indian Health Service region, 2001–2005.
Southern Plains, 12.1; Southwest, 14.4; Northern Plains, West, 23.8;
Northern Plains, East, 25.6; Alaska, 28.6; East, 31.1; West, 35.4. Texas is
partitioned into three regions which fall under the jurisdiction of the
Southwest, Southern Plains or East IHS regions.
doi:10.1371/journal.pone.0005255.g002
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integrity (i.e., diaper rash, impetigo), and are referred to here as
‘atopic dermatitis’ and ‘other skin conditions’, respectively. The
relative frequency of both categories of concurrent skin condition
across different age groups is shown in Figure 5. In the AI/AN
population, such conditions, particularly ‘atopic dermatitis’, were
most prominent among children under 15 years of age and among
individuals $65 years of age. Conditions associated with loss of skin
integrity, such as acne and keratosis, were more prominent among
adolescents (15–19 years old) and adults 45–64 years old, but these
age groups experienced the lowest overall frequencies of concurrent
skin conditions, with only 1.8% of adolescents and 4.6% of adults 45–
64 experiencing concurrent conditions, whereas 9.0% and 25.0% of
infants and persons $65 years, respectively, received such diagnoses.
Patients noted to have atopic dermatitis did not, on average,
have a greater number of MC-associated clinic visits.
Ten patients (with 13 visits) had concurrent diagnosis of human
immunodeficiency virus (HIV) infection.
Figure 3. Proportion of molluscum contagiosum-associated outpatient visits occurring January–December among American
Indian/Alaska Native persons, 2001–2005.
doi:10.1371/journal.pone.0005255.g003
Table 2. Characteristics of molluscum contagiosum-associated outpatient visits per patient and average annual incidence among
American Indians and Alaska Natives by region, 2001–2005.
Location*
Characteristic Alaska East
Northern
Plains, East
Northern
Plains, West
Southern
Plains Southwest West Overall IHS
No. Rate
{ No. Rate
{ No. Rate
{ No. Rate
{ No. Rate
{ No. Rate
{ No. Rate
{ No. Rate
{
Sex
Male 626 21.10 200 21.40 396 18.62 802 17.83 728 10.64 1198 10.62 1025 26.62 4975 15.31
Female 670 21.65 241 24.28 415 18.68 877 18.63 687 8.91 1420 11.29 1156 27.3 5466 15.38
Age Group (years)
,1 27 22.78 14 55.82 6 11.12 36 22.69 29 16.18 51 12.92 35 38.60 198 19.40
1–4 522 97.59 186 123.62 322 96.30 709 85.0 583 51.81 1082 54.24 888 150.08 4292 77.12
5–14 530 40.35 197 50.27 392 43.5 708 35.66 584 20.19 961 18.98 1007 60.24 4379 30.79
15–19 63 9.86 13 7.04 39 8.44 78 7.67 70 4.90 126 5.06 74 8.51 463 6.52
20–44 134 6.36 29 4.07 42 2.65 123 3.68 119 2.22 354 3.99 148 5.05 949 3.81
45–64 17 1.73 1 0.30 10 1.35 22 1.57 25 1.0 35 0.96 26 1.83 136 1.24
$65 3 0.82 1 0.80 0 – 3 0.64 5 0.47 9 0.65 3 0.59 24 0.57
Total visits 1296 21.38 441 22.88 811 18.65 1679 18.24 1415 9.72 2618 10.97 2181 26.96 10,441 15.34
*see Figure 2 [map of US with different geographic regions highlighted].
{Rate of outpatient visits involving molluscum contagiosum per 10,000 AI/AN population within the IHS healthcare system in the specified region (for individuals who
had multiple clinic visits involving molluscum contagiosum during the study period, only the first annual visit is included).
doi:10.1371/journal.pone.0005255.t002
Molluscum contagiosum
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Molluscum contagiosum-associated visits
Medical procedures coinciding with MC-associated visits were
assessed over the five-year period of observation by reviewing
procedure codes recorded for each patient visit (Table 4). During
that time, 273 procedures (e.g., vaccine administration, respiratory
measure, gynecologic exam, etc.) were recorded in conjunction
with MC-associated outpatient visits, but only a single category of
dermal procedure was noted. This general category (ICD-9-CM
procedure 86.3) encompasses varied forms of mechanical disrup-
tion of lesions or skin—cauterization cryosurgery, fulguration and
laser excision. (This code excludes biopsy, however). Though
rarely performed within any age group, MC-associated outpatient
visits were most frequently accompanied by mechanical lesion
disruption among patients in the 20–44 and 45–64 year old age
groups, accounting for only 4.3% and 9.2% of visits, respectively.
There we no prescribed medications for MC treatment noted.
Discussion
Despite the ubiquity of MCV throughout the world, few recent
studies have addressed incidence trends or burden of infection
associated with this virus, and none that we know of have provided
population-based rates to describe incidence or health care
utilization. The purpose of this study has been to provide a
comprehensive view of epidemiology of MC across different age
groups and in different parts of the United States, by utilizing the
health service information for AI/AN persons available through
the IHS, which affords a more detailed accounting of outpatient
service utilization than is available for the general US population.
Our findings point to a relatively high overall MC-associated
outpatient visit rate in the AI/AN population (20.15/10,000 AI/
AN persons). This rate is comparable to that estimated for the US
population overall, although the rate for AI/AN persons living in
the West, East and Alaska regions may be higher than that for the
general US population.
A national survey of MC-associated physician visits performed
over two decades ago, using data obtained from the National
Disease Therapeutic Index Survey (NDTIS) of the United States
demonstrated an increase in the proportion of MC-associated
clinic visits (per total clinic visits) during a 18-year period from
1966 to 1983, ranging from 1.2 to 11 MC-associated visits per
100,000 clinic visits [21]. In contrast, here, we saw relatively high
but stable incidence rates over the 5-year period of observation. It
is important to note, however, that ‘clinic visits’ were used as the
denominator for MC-associated health care utilization rates in the
NDTIS study, whereas in this study we report annual MC-
associated outpatient incidence per 10,000 AI/AN persons,
therefore rates are not directly comparable.
In addition to high overall incidence, we note relatively high
incidence among specific population sub-groups, notably 1–4 year
olds in the East and West regions where incidence rates of 123.62/
10,000 and 150.08/10,000, respectively, were reported. These
incidence rates are comparable to that for chickenpox prior to
initiation of vaccination (1980–1990), which was estimated to be
149.8/10,000 [22]. Recent studies which measured age-related
health care utilization for MC concluded that rates of health care
utilization, and overall numbers of MC-associated visits were
highest among children 2–5 years old [7,23]. Formerly, onset of
schooling was typically viewed as a social risk factor for acquisition
of MC, particularly in developed, affluent nations [1]; a study
performed in Holland in the late 1980s provided evidence
consistent with this idea [11]. However, increased utilization of
child day care in the United States during the last two decades has
generally lowered the age of socialization (outside the immediate
household) among children across most socio-economic strata
[24]. It bears further consideration whether the observed elevated
burden of infection observed among pre school-aged children in
this study reflects general tendencies toward communal care of
very young children in the AI/AN population, or possibly
heightened utilization of child daycare.
Independent of age, both poverty and crowded living quarters
have been hypothesized as general risk factors to account for
perceived higher rates of MCV particularly in the tropics [1,8].
Moisture and humidity have been implicated as relevant climatic
factors as well [1,5,25], but the strength of association between
poverty, geography or climate, and incidence of infection with
MCV remains undetermined. In our study, overall incidence of
MC-associated clinic visits was observed to be highest in the
West, East and Alaska regions, and lowest in the Southwest and
Southern Plains regions, the latter of which are arguably the
areas with warmest climate. These regional differences in
Table 3. Number of patients with incidence of molluscum
contagiosum in the American Indian/Alaska Native
population, 2001–2005.*
Year
Patients with
at least one
MC-associated
clinic visit
Change
from
Previous year
Annual
rate/10,000
Change
from
previous year
2001 1982 na 15.10 na
2002 1925 23.0% 14.38 25.0%
2003 2116 +9.0% 15.59 +7.8%
2004 2121 +0.2% 15.33 21.7%
2005 2297 +7.7% 16.27 +5.8%
*Outpatient visits involving molluscum contagiosum among the AI/AN
population within the IHS healthcare system.
doi:10.1371/journal.pone.0005255.t003
Figure 4. Proportion of patients with molluscum contagiosum
(MC) indicated as the principal diagnosis versus ancillary
diagnosis, stratified by number of visits per patient among
American Indian/Alaska Native persons, 2001–2005. Stripped
bars represent proportion of patients with MC as the principal
diagnosis; solid bars represent the proportion of patients with MC as
an ancillary diagnosis. (*) 0.05 and 0.15% of patients experienced 8 or
more MC-associated outpatient visits, respectively.
doi:10.1371/journal.pone.0005255.g004
Molluscum contagiosum
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seems unlikely that the observed differences could be attributable
to climate alone.
For individual AI/AN patients, however, the presence of
concurrent skin conditions was often attendant MC-associated
visits. For purposes of this study, these conditions were broadly
categorized into those associated with immune deficits with
dermatologic manifestations, for example atopic dermatitis and
eczema, versus those suggestive of breaches in skin integrity, such
as acne and impetigo. Conditions in either category could
predispose persons to MCV infection (eczema is a risk factor for
severe complications from infection with poxviruses and other
cutaneous viral pathogens) but, notably, the relative frequencies of
each category of skin condition varied in line with MC patient age.
Atopic dermatoses were diagnosed concurrently with MC in
approximately 8% of all persons under the age of 14, and in
,18% of persons $65 years of age, but these diagnoses were
relatively infrequent among persons 15–64 years old. Conversely,
among 15–64 year olds, a greater proportion of patients were
diagnosed with acne or erythematos conditions, both associated
with loss of skin integrity. These observations suggest that risk
reduction messages tailored for AI/AN patients of specific ages
could be useful in preventing MCV infections. (For example,
teenagers with acne should be enjoined to take special care when
interacting with a younger sibling that has MCV infection.)
This study demonstrates that within the AI/AN population in
the United States there is appreciable utilization of health care
services for MCV infection, but there appears to be a relative
absence of use of specific medical interventions which could be
employed to diminish the consequences of infection (although
prescription treatments were not specifically assessed). Pediatric and
adult treatment options include curettage and application of various
topical agents [26,27]. The risk of MCV transmission and
subsequent infection (either to oneself or to others) can be lessened
bysuccessful useofinterventionsthat hastenthe resolution of lesions.
But physicians need always to balance the potential value of the
intervention against the potential risks, i.e., scarring, pain, etc. [26].
The IHS/tribal and the general US population outpatient visit
data are very useful for evaluation, although there are some
limitations to the data. Only AI/AN persons who had received
medical evaluation for MC are included in the estimate in this
study, therefore the incidence rate reported here may be an
underestimate of the true incidence rate of MC occurrence in the
AI/AN population, and regional variations in health-care seeking
behavior may exist. Also, diagnoses may be incomplete, miscoded
or vary by region. The AI/AN user population is an estimate of
the number of AI/AN persons who are eligible to utilize the IHS
healthcare system and may not include all AI/AN persons who
seek medical consultation. Further, the AI/AN persons in this
study are not representative of all AI/AN persons in the United
States. For the general US population, only the overall MC
outpatient visit rates were estimated due to the small number of
MC visits in the surveys. Also, multiple outpatient visits for
individual patients are not identified; therefore, the incidence of
MC can not be estimated for the general US population.
Figure 5. Proportion of molluscum contagiosum-associated outpatient visits among American Indian/Alaska Native persons by age
for which concurrent skin conditions were recorded, 2001–2005. Total number of outpatient visits per age groups shown in parentheses. ({)
Denotes skin conditions associated with loss of skin integrity (impetigo, diaper rash, unspecificed erythematos conditions, acne); (*) denotes skin
conditions potentially associated with immune deficits (eczema/contact dermatitis, atopic dermatitis).
doi:10.1371/journal.pone.0005255.g005
Table 4. Number of molluscum contagiosum-associated
outpatient visits for which a mechanical removal procedure
was performed in the American Indian/Alaska Native
population, 2001–2005.*
Age (years) Number (%) of visits involving procedure {
,1 0 (0)
1–4 66 (1.15)
5–14 122 (2.12)
15–19 16 (2.18)
20–44 52 (4.25)
45–64 16 (9.20)
$65 1 (2.27)
Total 273
*Outpatient visits involving molluscum contagiosum among the AI/AN
population within the IHS healthcare system.
{Included under this procedure category are cauterization cryosurgery,
fulguration and laser excision.
doi:10.1371/journal.pone.0005255.t004
Molluscum contagiosum
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5255In sum, this study highlights the need for periodic population-
based measurements to assess long-term trends in incidence and
healthcare utilization for MC, particularly as regards the age of
initial MCV acquisition, associations with other concurrent skin
conditions, and availability and use of medical interventions.
Though this study specifically addresses MC-associated health
care utilization in the AI/AN population in the United States, our
results highlight features of MC epidemiology that merit further
consideration and evaluation for other populations in the United
States and elsewhere. Because the need seems great, the AI/AN
population should benefit from community outreach regarding
MC prevention, particularly in very young children.
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